NCT00003649 2023-06-22
Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed
Eastern Cooperative Oncology Group
Phase 1 Completed
Clinical Trials
10 trialsNCT00003450 2021-02-02
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT00004041 2018-06-27
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00044993 2013-05-30
Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003588 2013-02-08
Gene Therapy in Treating Patients With Ovarian Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004038 2013-02-07
Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003167 2013-01-23
Gene Therapy in Treating Patients With Advanced Bladder Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00064103 2013-01-23
Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00004225 2010-07-07
Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00286247 2008-04-01
Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer
Introgen Therapeutics
Phase 2 Completed